Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/69670
- Title:
- Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY)
- Universidade de São Paulo (USP)
- Universidade Federal de São Paulo (UNIFESP)
- Universidade Estadual Paulista (UNESP)
- Instituto Fleury
- 0049-3848
- Introduction: Venous thrombosis (VT) and inflammation are two closely related entities. In the present investigation we assessed whether there is a relation between genetic modifiers of the inflammatory response and the risk of VT. Materials and methods: 420 consecutive and unrelated patients with an objective diagnosis of deep VT and 420 matched controls were investigated. The frequencies of the following gene polymorphisms were determined in all subjects: TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G. Results: Overall odds ratio (OR) for VT related to TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, A1 allele (4 bp repeat) of the IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G were respectively: 1.0 (CI95: 0.8-1.5), 1.3 (CI95: 1.0-1.7), 1.1 (CI95: 0.9-1.5), 1.6 (CI95: 1-2.5), 1.2 (CI95: 0.8-1.7) and 0.8 (CI95: 0.6-1.1). A possible interaction between polymorphisms was observed only for the co-inheritance of the mutant alleles of the LT-α+ 252 A/G and IL-10-1082 G/A polymorphisms (OR = 2; CI95: 1.1-3.8). The risk of VT conferred by factor V Leiden and FII G20210A was not substantially altered by co-inheritance with any of the cytokine gene polymorphisms. Conclusions: Cytokine gene polymorphisms here investigated did not significantly influence venous thrombotic risk. © 2006 Elsevier Ltd. All rights reserved.
- 21-May-2007
- Thrombosis Research, v. 120, n. 2, p. 221-229, 2007.
- 221-229
- Coagulation
- Cytokines
- Inflammation
- Polymorphisms
- Thrombosis
- Venous thromboembolism
- blood clotting factor 11
- blood clotting factor 5 Leiden
- CD31 antigen
- cytokine
- interleukin 1 receptor blocking agent
- interleukin 10
- interleukin 6
- lymphotoxin
- tumor necrosis factor alpha
- cardiovascular risk
- deep vein thrombosis
- genetic polymorphism
- inflammation
- major clinical study
- medical research
- Base Sequence
- Case-Control Studies
- DNA Primers
- Interleukin 1 Receptor Antagonist Protein
- Interleukin-10
- Interleukin-6
- Lymphotoxin-alpha
- Middle Aged
- Odds Ratio
- Polymorphism, Genetic
- Tumor Necrosis Factor-alpha
- Variation (Genetics)
- Venous Thrombosis
- http://dx.doi.org/10.1016/j.thromres.2006.09.015
- Acesso restrito
- outro
- http://repositorio.unesp.br/handle/11449/69670
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.